Follow the Journey Medical Corp share price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Operating in the Health Care sector, Journey Medical Corp has logged 72 insider filings. Market capitalisation: €170.4m. The latest transaction was filed on 26 June 2026 (Attribution). Among the most active insiders: Maraoui Claude. Every trade is free.
72
Insider Decl.
n/a
Thresholds
€707,018
9 ops.
Buy Volume
€740,002
18 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Journey Medical Corp Strong Buy (bullish), based on 4 analysts. Average price target: US$13.50.
37Σ signal
Buys €707,018€740,002 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,040 of 28,717 companies
27.8
score / 100
Value
21
Quality
35
FCF yld-5.7%
Earn yld-5.2%
EV/EBITDA·
ROE-24%
Gross mgn66%
Net mgn-18%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
80,000 shares0Common Stock, $0.0001 par valueSEC:0001104659-25-035598:0
25 of 72 declarations
About Journey Medical Corp
Journey Medical Corp is a company focused on the development and commercialization of dermatological treatments. It is listed on NASDAQ under the ticker XNAS.